Is the writing on the wall?

Quote

anonymous said:
two different analysts asked for the breakdown of blind versus sighted patients receiving Hetlioz and received the same song and dance as they did in Q2. Why do the CEO and CFO either continually lie or be completely evasive to analysts and shareholders? CEO stands for Criminally Evasive Ogre.
Click to expand...
I loved the continual blame on payers that sales aren't higher. Using one bizarre rejection as the case was pathetic. Most payers will continue to reject hetlioz since these patients don't have non 24, they have insomnia and hetlioz is not indicated for insomnia and there are many medications for insomnia that are much better than the sugar pill called Hetlioz that costs nearly $200000 per year.
 


absolutely incredible. The level of arrogance by Poly. Unfortunately, investors, through the share price, are rewarding him for this behavior. He is emboldened. Now, going to try to fight FDA. This could be a big misstep.
Also, the pricing is hilarious -- just look in the SEC filings, it clearly states that payer do not think Hetlioz is "cost effective." But Poly continues to tell investors that price is not a point of negotiation because it is priced appropriately. He must not engage at all with the non-24 community. Everyone would tell him that price is an issue, whether they are on the drug, can't get the drug, or have not even tried because of the prohibitive process/price. Just goes to show how detached he is and how little he actually cares about patients. All he cares about are intakes and ability to recognize revenues.
 


anonymous said:
absolutely incredible. The level of arrogance by Poly. Unfortunately, investors, through the share price, are rewarding him for this behavior. He is emboldened. Now, going to try to fight FDA. This could be a big misstep.
Also, the pricing is hilarious -- just look in the SEC filings, it clearly states that payer do not think Hetlioz is "cost effective." But Poly continues to tell investors that price is not a point of negotiation because it is priced appropriately. He must not engage at all with the non-24 community. Everyone would tell him that price is an issue, whether they are on the drug, can't get the drug, or have not even tried because of the prohibitive process/price. Just goes to show how detached he is and how little he actually cares about patients. All he cares about are intakes and ability to recognize revenues.
Click to expand...
See "Dear Associate Reps " thread and a few of the older threads. Representatives that refused to break federal law were purged by MP, GP and TG. But being jobless is better than federal prison.
 


anonymous said:
absolutely incredible. The level of arrogance by Poly. Unfortunately, investors, through the share price, are rewarding him for this behavior. He is emboldened. Now, going to try to fight FDA. This could be a big misstep.
Also, the pricing is hilarious -- just look in the SEC filings, it clearly states that payer do not think Hetlioz is "cost effective." But Poly continues to tell investors that price is not a point of negotiation because it is priced appropriately. He must not engage at all with the non-24 community. Everyone would tell him that price is an issue, whether they are on the drug, can't get the drug, or have not even tried because of the prohibitive process/price. Just goes to show how detached he is and how little he actually cares about patients. All he cares about are intakes and ability to recognize revenues.
Click to expand...
Poly would personally like out eyeballs to make someone blind and them ask if they would like Hetlioz.
 





Write your reply...
Top Bottom
Back
Quote